Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Immune cytokines as a bridge linking the gut-liver-ovary axis in the pathogenesis of premature ovarian failure

Xu H., Li M., Yang S., Jiang D.

Narrative Review on Autoimmune Research, published in Front Endocrinol (Lausanne) (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Front Endocrinol (Lausanne) (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41858855
PMCID
PMC12995609
DOI
10.3389/fendo.2026.1758707

Abstract (original English)

Premature ovarian failure (POF) is a multifactorial disorder characterized by the progressive decline of ovarian function, in which autoimmune factors account for approximately 10%-30% of cases. Accumulating evidence has demonstrated that immune-related mediators, including regulatory T cells (Tregs), interferon-γ (IFN-γ), and T helper 17 (Th17) cells, play pivotal regulatory roles in its initiation and progression. In recent years, the gut-liver axis and its potential mechanistic links with POF have emerged as a research hotspot in this field. Notably, these pathways are closely associated with the expression and functional balance of key immune mediators such as Tregs, IFN-γ, and Th17 cells. Based on the bridging role of immune cytokines between POF and the gut-liver axis, we propose a novel conceptual framework in which immune cytokines serve as a central hub to systematically elucidate the intrinsic connections among POF, gut microbiota dysbiosis, and bile acid metabolism. Furthermore, we highlight the current limitations of existing studies in this area. This perspective may provide a new theoretical framework for understanding the pathogenesis of POF and holds significant scientific value. Importantly, it may also offer novel insights and potential evidence for expanding clinical diagnostic and therapeutic strategies.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
LiverOvaryAnimalsHumansCytokinesFemaleT-Lymphocytes, RegulatoryPrimary Ovarian InsufficiencyGastrointestinal Microbiome

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research